Welcome to our dedicated page for Alignment Healthcare SEC filings (Ticker: ALHC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Tracking how Alignment Healthcare, Inc. (NASDAQ: ALHC) earns capitation revenue or manages its medical loss ratio can mean sifting through hundreds of SEC pages. Complex items—CMS risk-adjustment methodology, provider network agreements, or value-based care metrics—often hide in footnotes. Stock Titan’s AI-powered summaries turn those dense disclosures into plain-English insights, so you see the numbers and the nuance without scanning every line.
Whether you need an Alignment Healthcare annual report 10-K simplified or the latest Alignment Healthcare quarterly earnings report 10-Q filing, this page delivers every document the moment it hits EDGAR. Our platform automatically tags material events, making the next Alignment Healthcare 8-K material events explained easy to spot. Real-time alerts highlight Alignment Healthcare insider trading Form 4 transactions and send instant notifications when executives buy or sell shares—ideal for monitoring Alignment Healthcare executive stock transactions Form 4.
Here’s how professionals use these filings:
- Compare member growth trends quarter-over-quarter without wading through actuarial tables.
- Review risk-score disclosures before earnings calls using our AI commentaries.
- Evaluate leadership incentives with the Alignment Healthcare proxy statement executive compensation section pre-highlighted.
Every form—10-K, 10-Q, 8-K, S-1, and more—is indexed, and AI-powered summaries explain filing meanings in simple terms. Need to dive deeper? Open the full document alongside side-by-side analytics that clarify revenue recognition or contract liabilities. From Alignment Healthcare earnings report filing analysis to understanding Alignment Healthcare SEC documents with AI, you’ll find what matters faster, make informed decisions sooner, and never miss another Alignment Healthcare Form 4 insider transactions real-time update.
Form 144 notice for Alignment Healthcare, Inc. (ALHC) reports a proposed sale of 35,000 shares of common stock through E-Trade with an aggregate market value of $555,100, and an approximate sale date of 09/08/2025. The filing lists 198,031,417 shares outstanding. The securities to be sold were originally acquired as a stock award on 09/06/2023 under the issuer's 2021 Equity Incentive Plan, showing 61,256 shares acquired on that date. The filing also discloses prior sales under a 10b5-1 plan: 15,491 shares sold on 07/31/2025 for gross proceeds of $247,950.50. Other filer contact and CIK details are not provided in the document content.
Alignment Healthcare, Inc. (ALHC) filing a Form 144 notifies a proposed sale of 35,000 shares of common stock via E-Trade with an aggregate market value of $555,100, to be sold on 09/08/2025 on the Nasdaq Stock Market. The shares were acquired on 09/12/2022 from the vesting of restricted stock units under the company's 2021 Equity Incentive Plan. The filer also reported prior sales under a 10b5-1 plan on 06/10/2025 (60,000 shares, $876,048) and 06/11/2025 (40,863 shares, $621,207.50). The notice includes the standard representation that the seller is unaware of undisclosed material adverse information.
Alignment Healthcare, Inc. (ALHC) filing a Form 144 notifies the proposed sale of 120,000 shares of common stock through E-Trade, with an aggregate market value of $1,903,200. The filer acquired the securities as restricted stock units that vested on 09/12/2022 (215,662 units granted under the 2021 Equity Incentive Plan). The filing reports recent Rule 10b5-1 plan sales by the same seller: three sales of 30,000 shares each on 06/16/2025, 07/14/2025, and 08/13/2025, generating gross proceeds of $434,280, $403,347, and $447,108 respectively. The filing includes the standard representation that the seller is not aware of undisclosed material adverse information.
Alignment Healthcare (ALHC) filed a Form 144 reporting a proposed sale of 380,000 shares of Common Stock through E-Trade, with an aggregate market value of $6,026,800 and an approximate sale date of 09/08/2025 on the Nasdaq Stock Market. The filer acquired 819,514 shares on 09/12/2022 via vesting of restricted stock units granted under the 2021 Equity Incentive Plan.
The filing also discloses recent sales executed under a Rule 10b5-1 plan by JEK Trust totaling 540,000 shares across four transactions in June–August 2025, with combined gross proceeds shown in the filing. The notice includes the standard signer representation about absence of undisclosed material adverse information.
Andreas P. Wagner, Chief Human Resources Officer at Alignment Healthcare, Inc. (ALHC), reported an insider sale. The Form 4 shows a sale of 12,032 shares of the company's common stock on 08/25/2025 at a price of $16.47 per share, leaving Mr. Wagner with 192,043 shares beneficially owned after the transaction. The filing indicates the sale was made pursuant to a Rule 10b5-1 trading plan adopted on 03/11/2025.
Form 144 notice: An insider proposes to sell 12,032 shares of common stock of the issuer through Morgan Stanley Smith Barney LLC, with an aggregate market value of $190,586.88, and an approximate sale date of 08/25/2025 on NASDAQ. The shares were acquired as restricted stock units on 02/07/2025 and paid on that date. The filing discloses prior 10b5-1 plan sales by the same person on 06/11/2025 totaling 19,399 shares for gross proceeds of $296,042.27. The filer attests there is no undisclosed material adverse information.
Alignment Healthcare (ALHC) insider Form 4: The filing shows Hyong (Ken) Kim, identified as Chief Medical Officer and an officer of the company, reported an open-market sale of 24,800 shares of the issuer's common stock on 08/22/2025 at a reported price of $16 per share. After the sale, Mr. Kim beneficially owned 447,367 shares, held directly. The Form 4 notes the transaction was made pursuant to a Rule 10b5-1 trading plan adopted on 03/14/2025. The form is signed by Christopher J. Joyce as attorney-in-fact on 08/22/2025.
Alignment Healthcare insider sale notice: The filing reports that 24,800 shares of Alignment Healthcare common stock are proposed for sale via Morgan Stanley Smith Barney, with an aggregate market value of $391,840, and an approximate sale date of 08/22/2025 on NASDAQ. The shares were acquired 03/06/2021 as pre-IPO shares issued in exchange for partnership units. The filer reports two prior 10b5-1 sales by Hyong J Kim on 08/11/2025 and 08/13/2025, each showing 18,600 shares sold generating gross proceeds of $270,425.40 and $279,608.22 respectively. The filing includes the standard representation that the seller is not aware of undisclosed material adverse information.
Alignment Healthcare Chief Medical Officer Hyong (Ken) Kim reported the sale of 18,600 shares of the company’s common stock on 08/13/2025 under a Rule 10b5-1 trading plan adopted on 03/14/2025. The sales generated a weighted-average price of $15.0327 per share, with individual trades executed between $15.00 and $15.09. After the reported transactions, the reporting person beneficially owned 472,167 shares. The Form 4 was signed by an attorney-in-fact on behalf of the reporting person and discloses the plan adoption date and the price range for the multiple sales.
Alignment Healthcare insider sale under a 10b5-1 plan: Dawn C. Maroney, President and officer of Alignment Healthcare (ALHC), reported a planned disposition of 30,000 shares of common stock on 08/13/2025 at a weighted-average price of $14.9036 per share, executed under a Rule 10b5-1 trading plan adopted 11/25/2024. After the sale, Maroney beneficially owns 2,012,899 shares directly. The filing notes the sale prices ranged from $14.64 to $15.13 and that full allocation details by price will be provided on request.
FAQ
What is the current stock price of Alignment Healthcare (ALHC)?
What is the market cap of Alignment Healthcare (ALHC)?
